Address
PAC-LINK Management Corp
8 Xingyi Road
20F Shanghai Maxdo Center
Shanghai
31
China
Website
VCID: 1704
Profile
Corporate information
Investment activity status
Active investor
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 | Series D |
|
|
|
DiObex Inc Biotechnology company that develops novel products for the treatment of metabolic disorders. |
United States | 16 Apr 2007 | Series B |
|
|
|
GlobeImmune Inc Biopharmaceuticals company. |
United States | N/A |
||
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
Synacom Technology Inc |
United States | N/A |
||
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Epitomics Inc |
United States | N/A Active |
||
|
|
Ascenta Therapeutics Inc A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. |
United States | N/A |